FDA Inspection
MD Anderson Cord Blood BankMD Anderson Cord Blood Bank – FDA Inspection, Mar 2, 2018
Record Details
This FDA Inspection record concerns MD Anderson Cord Blood Bank, with an inspection on March 2, 2018, issued by the Dallas District Office, covering biologics.
- Office
- Dallas District Office
- People
- Bradley J. Dworak
- Heba A. Degheidy (Issuing Officer)
- Joyce A. Rockwell (Issuing Officer)
- Mercy O Quagraine (Issuing Officer)
- Prabhu P. Raju (FDA Associated Person)
View Company Profile
ID · 737619ad-244a-4538-9a70-efb362e0d805
Inspection Facts
- Inspection number
- 1048361
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of MD Anderson Cord Blood Bank
4| Date | Classification | Office | Project area |
|---|---|---|---|
| February 20, 2026 | NAI | Human Cellular, Tissue, and Gene Therapies | |
| September 16, 2024 | Not classified | Dallas District Office | |
| March 24, 2022 | VAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| December 12, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for MD Anderson Cord Blood Bank
- FDA Inspection 1305506 - 2026-02-20
- FDA Inspection 1250648 - 2024-09-16
- FDA Inspection 1165594 - 2022-03-24
- FDA Inspection 1115530 - 2019-12-12
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.